In this videocast from the International AIDS Society Conference in Sydney, Peter Staley interviews Dr. Fred Gordin from George Washington University, who explains why many experts think we might be waiting too long to put patients on HIV treatment. Dr. Gordin is also leading the effort to launch a large clinical trial called START, which hopes to determine if starting treatment at higher CD4 counts will save more lives.
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Previous Comments:
comments 1 - 2 (of 2 total)
Christina DeNully, Dayton, WA, 2007-07-27 20:35:07
Starting meds in the first 3 years of contracting the virus gives you a longer life in my opinion. I started meds in the first 3 years because I had a child. I now have 2 kids that don't have HIV. In the 1st 3 years of infection you're body is learning how to fight off HIV. If taking the meds at that point you're immune system isn't working overtime to fight it off. I have had HIV since I was 15 I am now 28! Viral load is undetectable and CD4 is 896. Why? I never stopped taking the meds.
Christina DeNully, Dayton, wa, 2007-07-27 20:34:21
Starting meds in the first 3 years of contracting the virus gives you a longer life in my opinion. I started meds in the first 3 years because I had a child. I now have 2 kids that don't have HIV. In the 1st 3 years of infection you're body is learning how to fight off HIV. If taking the meds at that point you're immune system isn't working overtime to fight it off. I have had HIV since I was 15 I am now 28! Viral load is undetectable and CD4 is 896. Why? I never stopped taking the meds.
Pipeline Preview: All The New AIDS Drugs Coming Soon Peter Staley reviews all the new experimental AIDS drugs with Dr. Joe Eron, including two non-nukes, and two new classes of drugs: CCR5 and integrase inhibitors.
Simple Test Eliminates Abacavir Risk Peter Staley asks Professor Simon Mallal from the Royal Perth Hospital about a simple new genetic test that accurately predicts if a patient is at risk for an allergic reaction to abacavir (Ziagen).
July 24, 2007
A Positive Papua New Guinean Speaks Out Against Stigma Regan Hofmann interviews Maura Elaripe Mea, the first HIV-positive woman to come forward publicly in her country. Through Igat Hope, the national network of people living with HIV/AIDS in PNG, Maura and others fight AIDS discrimination while spreading information and hope.
The Latest on Lipo: Advances & Setbacks Dr. Don Kotler discusses the latest from Sydney, both good and bad, on lipodystrophy treatments and cardiovascular risk in people with HIV.
Which HIV Meds Cause Lipoatrophy? In this videocast, Dr. Eric Daar provides an overview of which nukes, non-nukes, and protease inhibitors might cause fat loss, and which ones probably won't.
Are We Starting Treatment Early Enough? In this videocast, Dr. Fred Gordin explains why many experts think we might be waiting too long to put patients on HIV treatment.
Fauci Defends Bush's AIDS Legacy Peter Staley interviews Tony Fauci about his research on HIV "eradication," President Bush's AIDS legacy, why he likes gay men and Republicans, and that letter he wrote supporting Scooter Libby.
Regan Hofmann talks with Dr. Nancy Padian about PrEP, microbicides, and circumcision, and asks "when can my boyfriend and I stop using condoms." 
Peter Staley reviews all the new experimental AIDS drugs with Dr. Joe Eron, including two non-nukes, and two new classes of drugs: CCR5 and integrase inhibitors. 
Peter Staley asks Professor Simon Mallal from the Royal Perth Hospital about a simple new genetic test that accurately predicts if a patient is at risk for an allergic reaction to abacavir (Ziagen).
Regan Hofmann interviews Maura Elaripe Mea, the first HIV-positive woman to come forward publicly in her country. Through Igat Hope, the national network of people living with HIV/AIDS in PNG, Maura and others fight AIDS discrimination while spreading information and hope.
Dr. Don Kotler discusses the latest from Sydney, both good and bad, on lipodystrophy treatments and cardiovascular risk in people with HIV. 
In this videocast, Dr. Eric Daar provides an overview of which nukes, non-nukes, and protease inhibitors might cause fat loss, and which ones probably won't.
In this videocast, Dr. Fred Gordin explains why many experts think we might be waiting too long to put patients on HIV treatment.
A videocast interview with Professor Brian Gazzard, an expert on HIV and aging.
Peter Staley interviews Tony Fauci about his research on HIV "eradication," President Bush's AIDS legacy, why he likes gay men and Republicans, and that letter he wrote supporting Scooter Libby.